Effectiveness of Dupilumab for an Elderly Patient with Prurigo Nodularis Who Was Refractory and Contradicted to Traditional Therapy

• Main Authors: Liu T, Bai J, Wang S, Ying S, Li S, Qiao J, Fang H
• Format: Article
• Language: English
• Published: Dove Medical Press 2021-03-01
• Series: Journal of Asthma and Allergy
• Subjects: prurigo nodularis; dupilumab; elderly patient; targeted therapy
• Online Access: https://www.dovepress.com/effectiveness-of-dupilumab-for-an-elderly-patient-with-prurigo-nodular-peer-reviewed-article-JAA
• ISSN: 1178-6965

Taoming Liu, Juan Bai, Su Wang, Shuni Ying, Sheng Li, Jianjun Qiao, Hong Fang Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence: Jianjun Qiao; Hong FangDepartment of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, People’s Republic of ChinaTel/Fax [phone]Email [e-mail]; [e-mail]: Prurigo nodularis (PN) is an intense pruritic skin condition. Treatment of PN is challenging. We described an elderly patient with PN who had contradictions of cyclosporine or methotrexate and achieved significant improvement after treatment with dupilumab. We also reviewed published cases of elderly patients with PN who were refractory to traditional therapy.Keywords: prurigo nodularis, dupilumab, elderly patient, targeted therapy